SCHEMBL753785

SCHEMBL753785

CC1(C)NC(=O)NC1=O.[Ag]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.37
LMNA P02545 2/20 0.36
MMP2 P08253 2/20 0.34
MMP9 P14780 2/20 0.34
CACNA1F O60840 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HTR2A P28223 1/20 0.34
HRH1 P35367 1/20 0.34
SCN1A P35498 1/20 0.34
SCN4A P35499 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
CACNA1D Q01668 1/20 0.34
KCNH2 Q12809 1/20 0.34
CACNA1S Q13698 1/20 0.34
CACNA1C Q13936 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4558728 0.97 LMNA (0.38) ITGA4LMNAMMP2MMP9CACNA1F
SCHEMBL22069 0.97
SCHEMBL21196916 0.94
SCHEMBL6162987 0.94 LMNA (0.36) ITGA4LMNAMMP2MMP9CACNA1F
Methyl Alcohol SCHEMBL7188450 0.92 MMP2 (0.35) ITGA4LMNAMMP2MMP9CACNA1F
Formaldehyde SCHEMBL1396256 0.92 LMNA (0.35) ITGA4LMNAMMP2MMP9CACNA1F
Butadiene SCHEMBL1304779 0.85 GAA (0.32) LMNAMMP2MMP9CACNA1FALDH1A1
Ethylene Glycol SCHEMBL6848838 0.85 LMNA (0.36) LMNAMMP2MMP9POLBSMN1; SMN2
SCHEMBL3176115 0.83 ADAMTS5 (0.32) LMNAMMP2POLBAKR1B1
SCHEMBL10527679 0.83 AKR1B1 (0.31) LMNAAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250354268-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM ADEKA CORPORATION (JP) 2025-11-20 US claimed
CN-115216812-A Electrochemical preparation method of three-dimensional silver-based microstructure with high depth-to-width ratio 上海交通大学 2022-10-21 CN claimed
WO-2010065090-A2 ANTIMICROBIALS KING TECHNOLOGY, INC. (US) 2010-06-10 WO claimed
US-20100143430-A1 Antimicrobial agents KING JOSEPH A 2010-06-10 US claimed
US-20250354268-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM ADEKA CORPORATION (JP) 2025-11-20 US disclosed
WO-2023243394-A1 COMPOSITION, METHOD FOR PRODUCING COMPOSITION, AND METHOD FOR PRODUCING SILVER FILM 株式会社ADEKA 2023-12-21 WO disclosed
CN-115216812-A Electrochemical preparation method of three-dimensional silver-based microstructure with high depth-to-width ratio 上海交通大学 2022-10-21 CN disclosed
EP-2634293-B1 COMPOSITES OF CARBON BLACK AND METAL ROHM & HAAS ELECT MAT (US) 2018-07-18 EP disclosed
EP-2431502-B1 CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS ROHM & HAAS ELECT MAT (US) 2017-05-24 EP disclosed
US-20160096752-A1 WASTEWATER TREATMENT KING JOSEPH A (US) 2016-04-07 US disclosed
US-9228268-B2 Method of electroplating silver strike over nickel ROHM AND HAAS ELECTRONIC MATERIALS LLC 2016-01-05 US disclosed
US-9187351-B2 Water treatment KING TECHNOLOGY INC. (US) 2015-11-17 US disclosed
WO-2011056203-A2 WATER TREATMENT KING TECHNOLOGY, INC. (US) 2011-05-12 WO disclosed
US-20110094972-A1 Water treatment KING TECHNOLOGY, INC. 2011-04-28 US disclosed
US-20100140185-A1 Wastewater treatment HILL JOHN 2010-06-10 US disclosed
CN-1753702-A An assembly for the preparation of a medical device having a coating comprising hydrogen peroxide COLOPLAST AS (DK) 2006-03-29 CN disclosed
EP-1062383-A4 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LEARONAL INC (US) 2002-08-14 EP disclosed
US-6210556-B1 FOR DEPOSITING TIN-RICH TIN-SILVER ALLOYS UPON A SUBSTRATE LEARONAL, INC. 2001-04-03 US disclosed
EP-1062383-A1 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LeaRonal, Inc. (US) 2000-12-27 EP disclosed
WO-1999041433-A1 ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS LEARONAL, INC. (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110094972-A1 Water treatment HNMT, NAAA, MPO ITGA4 4615/4885LMNA 4253/4885MMP2 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.